ZYNE
Zynerba Pharmaceuticals, Inc
ZYNE
ZYNE
Delisted
ZYNE was delisted on the 10th of October, 2023.
41 hedge funds and large institutions have $1.74M invested in Zynerba Pharmaceuticals, Inc in 2023 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 7 increasing their positions, 12 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
Holders
41
Holding in Top 10
–
Calls
$11K
Puts
–
Top Buyers
| 1 | +$39.2K | |
| 2 | +$16.2K | |
| 3 | +$13K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$5.13K |
| 5 |
JPMorgan Chase & Co
New York
|
+$1.87K |
Top Sellers
| 1 | -$108K | |
| 2 | -$32K | |
| 3 | -$23.1K | |
| 4 |
VF
Virtu Financial
New York
|
-$14K |
| 5 |
HF
HRT Financial
New York
|
-$8K |